Even though the scientific relevance of your aforementioned cardiovascular threat factor alterations by tirzepatide is going to be assessed in the planned cardiovascular outcome examine SURPASS-CVOT ( "kind":"medical-trial","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Examination